Recent Characterization of Key Proteins to Combat Tuberculosis.

No abstract is available for this paper.

• Publication year

  2026

• Venue

  Advances in Experimental Medicine and Biology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-3-031-96883-9_10PMID 41207944
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genome-wide expression in human whole blood for diagnosis of latent tuberculosis infection: a multicohort research

  2025cited by this paper
• Novel fusion protein REA induces robust prime protection against tuberculosis in mice

  2025cited by this paper
• IFIT2-induced transcriptomic changes in Mycobacterium tuberculosis infected macrophages

  2025cited by this paper
• Comparative Performance of Urine Lipoarabinomannan and Urine Xpert MTB/RIF Ultra for Diagnosing Tuberculosis in Adult Inpatients With HIV in East London, South Africa

  2025cited by this paper
• The PE/PPE family proteins of Mycobacterium tuberculosis: evolution, function, and prospects for tuberculosis control

  2025cited by this paper
• Real-time visualization reveals Mycobacterium tuberculosis ESAT-6 disrupts phagosome-like compartment via fibril-mediated vesiculation

  2025cited by this paper
• Synthetic mycolates derivatives to decipher protein mycoloylation, a unique post-translational modification in bacteria

  2025cited by this paper
• Immunogenicity, safety, and efficacy of the vaccine H56:IC31 in reducing the rate of tuberculosis disease recurrence in HIV-negative adults successfully treated for drug-susceptible pulmonary tuberculosis: a double-blind, randomised, placebo-controlled, phase 2b trial.

  2025cited by this paper
• Screening and preclinical assessment of novel Mycobacterium tuberculosis recombinant antigens based tuberculin skin testing

  2025cited by this paper
• Tuberculosis vaccines and therapeutic drug: challenges and future directions

  2025cited by this paper
• Structure and assembly of the MmpL5/MmpS5 efflux transporter from Mycobacterium tuberculosis

  2025cited by this paper
• Unveiling the silent defenders: mycobacterial stress sensors at the forefront to combat tuberculosis

  2025cited by this paper
• The role of efflux pumps transporter in multi-drug resistant tuberculosis: Mycobacterial memberane protein(MmpL5)

  2024cited by this paper
• Mycobacterium tuberculosis Rv2617c is involved in stress response and phage infection resistance

  2024cited by this paper
• Description of Bacterial RNA Transcripts Detected in Mycobacterium tuberculosis – Infected Cells from Peripheral Human Granulomas using Single Cell RNA Sequencing

  2024cited by this paper
• Single-cell transcriptome sequencing reveals altered peripheral blood immune cells in patients with severe tuberculosis

  2024cited by this paper
• Rv2231c, a unique histidinol phosphate aminotransferase from Mycobacterium tuberculosis, supports virulence by inhibiting host-directed defense

  2024cited by this paper
• Identification of Novel Bacterial Microproteins Encoded by Small Open Reading Frames Using a Computational Proteogenomics Workflow.

  2024cited by this paper
• Structure–Function Analysis of the Essential Mycobacterium tuberculosis P450 Drug Target, CYP121A1

  2024cited by this paper
• ESAT-6 undergoes self-association at phagosomal pH and an ESAT-6-specific nanobody restricts M. tuberculosis growth in macrophages

  2024cited by this paper
• Microprotein-encoding RNA regulation in cells treated with pro-inflammatory and pro-fibrotic stimuli

  2024cited by this paper
• Transforming Clinical Research: The Power of High-Throughput Omics Integration

  2024cited by this paper
• The multiplicity of thioredoxin systems meets the specific lifestyles of Clostridia

  2024cited by this paper
• Microproteins/micropeptides dysregulation contributes to cancer progression and development: A mechanistic review

  2024cited by this paper
• C-terminal region of Rv1039c (PPE15) protein of Mycobacterium tuberculosis targets host mitochondria to induce macrophage apoptosis

  2024cited by this paper
• Structures of the mycobacterial MmpL4 and MmpL5 transporters provide insights into their role in siderophore export and iron acquisition

  2024cited by this paper
• Decoding the Role of CYP450 Enzymes in Metabolism and Disease: A Comprehensive Review

  2024cited by this paper
• Proteomic characterization of Mycobacterium tuberculosis subjected to carbon starvation

  2024cited by this paper
• The role of ESAT-6 in tuberculosis immunopathology

  2024cited by this paper
• Large Roles of Small Proteins.

  2024cited by this paper
• Functional unfoldomics: Roles of intrinsic disorder in protein (multi)functionality.

  2024cited by this paper
• MazEF toxin–antitoxin systems: their role in Mycobacterium tuberculosis stress response and drug resistance

  2024cited by this paper
• Evaluation of serological assays for the diagnosis of childhood tuberculosis disease: a study protocol

  2024cited by this paper
• Genome mining of Mycobacterium tuberculosis: targeting SufD as a novel drug candidate through in silico characterization and inhibitor screening.

  2024cited by this paper
• BCG-booster vaccination with HSP90-ESAT-6-HspX-RipA multivalent subunit vaccine confers durable protection against hypervirulent Mtb in mice

  2024cited by this paper
• In silico design of Mycobacterium tuberculosis multi-epitope adhesin protein vaccines

  2024cited by this paper
• Microproteins: Overlooked regulators of physiology and disease

  2023cited by this paper
• Structural and Biochemical Characterization of Mycobacterium tuberculosis Zinc SufU-SufS Complex

  2023cited by this paper
• Proteogenomics-based functional genome research: approaches, applications, and perspectives in plants.

  2023cited by this paper
• Design and Characterization of a Multistage Peptide-Based Vaccine Platform to Target Mycobacterium tuberculosis Infection

  2023cited by this paper
• Vaccines against Tuberculosis: Where Are We Now?

  2023cited by this paper
• Combining small angle X-ray scattering (SAXS) with protein structure predictions to characterize conformations in solution.

  2023cited by this paper
• Tale of Twin Bifunctional Second Messenger (p)ppGpp Synthetases and Their Function in Mycobacteria

  2023cited by this paper
• Temporal Profiling of Host Proteome against Different M. tuberculosis Strains Reveals Delayed Epigenetic Orchestration

  2023cited by this paper
• Integrated workflow for discovery of microprotein-coding small open reading frames

  2023cited by this paper
• Whole genome sequencing of drug resistance Mycobacterium tuberculosis from extra-pulmonary sites

  2023cited by this paper
• Tuberculosis vaccines update: Is an RNA-based vaccine feasible for tuberculosis?

  2023cited by this paper
• RNA G-quadruplexes inhibit translation of the PE/PPE transcripts in Mycobacterium tuberculosis

  2023cited by this paper
• Microproteins—Discovery, structure, and function

  2023cited by this paper
• Toxin release by conditional remodelling of ParDE1 from Mycobacterium tuberculosis leads to gyrase inhibition

  2023cited by this paper
• Research tests for the diagnosis of tuberculosis infection

  2023cited by this paper
• Proteomics in Biomarker Discovery for Tuberculosis: Current Status and Future Perspectives

  2022cited by this paper
• Development of peptide vaccine candidate using highly antigenic PE-PGRS family proteins to stimulate the host immune response against Mycobacterium tuberculosis H37Rv: an immuno-informatics approach

  2022cited by this paper
• Mycobacterium tuberculosis KasA as a drug target: Structure-based inhibitor design

  2022cited by this paper
• An early origin of iron–sulfur cluster biosynthesis machineries before Earth oxygenation

  2022cited by this paper
• Advances in data-independent acquisition mass spectrometry towards comprehensive digital proteome landscape.

  2022cited by this paper
• Mycobacterium tuberculosis requires SufT for Fe-S cluster maturation, metabolism, and survival in vivo

  2022cited by this paper
• Short open reading frames (sORFs) and microproteins: an update on their identification and validation measures

  2022cited by this paper
• The ESX-1 Substrate PPE68 Has a Key Function in ESX-1-Mediated Secretion in Mycobacterium marinum

  2022cited by this paper
• Immunogenicity and protection against Mycobacterium avium with a heterologous RNA prime and protein boost vaccine regimen.

  2022cited by this paper
• Peptide-Based Vaccines for Tuberculosis

  2022cited by this paper
• Current Use of Fenton Reaction in Drugs and Food

  2022cited by this paper
• Conserved and lineage-specific hypothetical proteins may have played a central role in the rise and diversification of major archaeal groups

  2022cited by this paper
• Mycobacterium tuberculosis exploits MPT64 to generate myeloid-derived suppressor cells to evade the immune system

  2022cited by this paper
• The Mycobacterium tuberculosis PE15/PPE20 complex transports calcium across the outer membrane

  2022cited by this paper
• Structural and functional characterization of a hypothetical protein in the RD7 region in clinical isolates of Mycobacterium tuberculosis — an in silico approach to candidate vaccines

  2022cited by this paper
• Prophage Gene Rv2650c Enhances Intracellular Survival of Mycobacterium smegmatis

  2022cited by this paper
• An analysis of proteogenomics and how and when transcriptome-informed reduction of protein databases can enhance eukaryotic proteomics

  2022cited by this paper
• A Peptidomic Approach to Identify Novel Antigen Biomarkers for the Diagnosis of Tuberculosis

  2022cited by this paper
• Phenotypic adaptation of Mycobacterium tuberculosis to host-associated stressors that induce persister formation

  2022cited by this paper
• Structural and Functional Characterization of Rv0792c from Mycobacterium tuberculosis: Identifying Small Molecule Inhibitor against HutC Protein

  2022cited by this paper
• A YoeB toxin cleaves both RNA and DNA

  2021cited by this paper
• Shotgun proteomic profiling of dormant, ‘non-culturable’ Mycobacterium tuberculosis

  2021cited by this paper
• The Role of Glycosylation in Infectious Diseases.

  2021cited by this paper
• Structure and dynamics of a mycobacterial type VII secretion system

  2021cited by this paper
• The Evaluation and Validation of Blood-Derived Novel Biomarkers for Precise and Rapid Diagnosis of Tuberculosis in Areas With High-TB Burden

  2021cited by this paper
• Understanding small ORF diversity through a comprehensive transcription feature classification

  2021cited by this paper
• Design of a peptide-based vaccine from late stage specific immunogenic cross-reactive antigens of PE/PPE proteins of Mycobacterium tuberculosis.

  2021cited by this paper
• Lipoarabinomannan as a Point-of-Care Assay for Diagnosis of Tuberculosis: How Far Are We to Use It?

  2021cited by this paper
• Host-Based Biomarkers in Saliva for the Diagnosis of Pulmonary Tuberculosis in Children: A Mini-Review

  2021cited by this paper
• Mycobacterium tuberculosis VapC4 toxin engages small ORFs to initiate an integrated oxidative and copper stress response

  2021cited by this paper
• Characterization of the MurT/GatD complex in Mycobacterium tuberculosis towards validating a novel anti-tubercular drug target

  2021cited by this paper
• IFI44L as a Forward Regulator Enhancing Host Antituberculosis Responses

  2021cited by this paper
• 19F-NMR reveals substrate specificity of CYP121A1 in Mycobacterium tuberculosis

  2021cited by this paper
• Surface hydrophobics mediate functional dimerization of CYP121A1 of Mycobacterium tuberculosis

  2021cited by this paper
• Compromised base excision repair pathway in Mycobacterium tuberculosis imparts superior adaptability in the host

  2021cited by this paper
• Immunogenicity of HspX/EsxS fusion protein of Mycobacterium tuberculosis along with ISCOMATRIX and PLUSCOM nano-adjuvants after subcutaneous administration in animal model.

  2021cited by this paper
• Metabolic Changes of Mycobacterium tuberculosis during the Anti-Tuberculosis Therapy

  2020cited by this paper
• DAR-901 vaccine for the prevention of infection with Mycobacterium tuberculosis among BCG-immunized adolescents in Tanzania: A randomized controlled, double-blind phase 2b trial.

  2020cited by this paper
• Shotgun EM of mycobacterial protein complexes during stationary phase stress

  2020cited by this paper
• Urine Lipoarabinomannan Testing for All HIV Patients Hospitalized in Medical Wards Identifies a Large Proportion of Patients With Tuberculosis at Risk of Death

  2020cited by this paper
• Integrative proteomic and glycoproteomic profiling of Mycobacterium tuberculosis culture filtrate

  2020cited by this paper
• Lineage-Specific Proteomic Signatures in the Mycobacterium tuberculosis Complex Reveal Differential Abundance of Proteins Involved in Virulence, DNA Repair, CRISPR-Cas, Bioenergetics and Lipid Metabolism

  2020cited by this paper
• VapC21 Toxin Contributes to Drug-Tolerance and Interacts With Non-cognate VapB32 Antitoxin in Mycobacterium tuberculosis

  2020cited by this paper
• The hidden world of membrane microproteins.

  2020cited by this paper
• PE/PPE proteins mediate nutrient transport across the outer membrane of Mycobacterium tuberculosis

  2020cited by this paper
• Hydroxylation of Antitubercular Drug Candidate, SQ109, by Mycobacterial Cytochrome P450

  2020cited by this paper
• CD4+ T cell proliferative responses to PPD and CFP-10 associate with recent M. tuberculosis infection.

  2020cited by this paper
• Characterization of a toxin-antitoxin system in Mycobacterium tuberculosis suggests neutralization by phosphorylation as the antitoxicity mechanism

  2020cited by this paper
• Mycobacterium tuberculosis Rv0341 Promotes Mycobacterium Survival in In Vitro Hostile Environments and within Macrophages and Induces Cytokines Expression

  2020cited by this paper

• No citing papers are available for this paper.